Literature DB >> 7143388

DHT-receptor in cultured human fibroblasts: binding study in a family with androgen insensitivity (complete testicular feminisation).

E Donti, I Nicoletti, P Filipponi, G Venti, V Bocchini, F Santeusanio.   

Abstract

3H-DHT binding was examined in cultured skin fibroblasts from a patient with complete testicular feminisation (CTF), from his heterozygote mother, and his clinically normal sister, who menstruated normally. Binding parameters were: Bmax less than 1 fmol/mg protein and KD unmeasurable in CTF; Bmax = 24 fmol/mg protein and KD = 3.63 X 10(-9) mol/l in the mother; and Bmax = 46 fmol/mg protein and KD = 3.7 X 10(-9) mol/l in the sister. Five cultures obtained from genital and non-genital skin of normal male and female subjects were used as controls, in which Bmax ranged from 37 to 62 fmol/mg and KD from 2.0 to 3.6 X 10(-9) mol/l. The considerable reduction of Bmax in the obligate heterozygote and the normal binding capacity in the sister, a probable heterozygote, suggests that it may be possible to use the DHT-receptor assay to identify carriers in families with androgen resistance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143388      PMCID: PMC1048919          DOI: 10.1136/jmg.19.5.349

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  12 in total

1.  Locus on human X chromosome for dihydrotestosterone receptor and androgen insensitivity.

Authors:  W J Meyer; B R Migeon; C J Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Androgen receptor in human skin fibroblasts. Characterization of a specific 17beta-hydroxy-5alpha-androstan-3-one-protein complex in cell sonicates and nuclei.

Authors:  B S Keenan; W J Meyer; A J Hadjian; C J Migeon
Journal:  Steroids       Date:  1975-04       Impact factor: 2.668

Review 3.  X-chromosome inactivation and developmental patterns in mammals.

Authors:  M F Lyon
Journal:  Biol Rev Camb Philos Soc       Date:  1972-01

4.  Syndrome of androgen insensitivity in man: absence of 5 alpha-dihydrotestosterone binding protein in skin fibroblasts.

Authors:  B S Keenan; W J Meyer; A J Hadjian; H W Jones; C J Migeon
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

Review 5.  The syndromes of androgen resistance.

Authors:  J E Griffin; J D Wilson
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

6.  Androgen insensitivity in man: evidence for genetic heterogeneity.

Authors:  J A Amrhein; W J Meyer; H W Jones; C J Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

7.  Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance.

Authors:  J E Griffin; K Punyashthiti; J D Wilson
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

8.  Studies on steroid hormone receptors (5alpha-dihidrotesterone, estradiol, and dexamethasone) in cultured human fibroblasts and amniotic fluid cells.

Authors:  T Bauknecht
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

9.  Specific 5alpha-dihydrotestosterone binding in labial skin fibroblasts cultured from patients.with male pseudohermaphroditism.

Authors:  M Kaufman; C Straisfeld; L Pinsky
Journal:  Clin Genet       Date:  1976-06       Impact factor: 4.438

10.  Male pseudohermaphroditism presumably due to target organ unresponsiveness to androgens. Deficient 5alpha-dihydrotestosterone binding in cultured skin fibroblasts.

Authors:  M Kaufman; C Straisfeld; L Pinsky
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

View more
  1 in total

1.  Carrier detection in the testicular feminisation syndrome: deficient 5 alpha-dihydrotestosterone binding in cultured skin fibroblasts from the mothers of patients with complete androgen insensitivity.

Authors:  M B Hodgins; E M Duke; D Ring
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.